1UK Prospective Diabetes Study (UKPDS) Group. Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS33)[J].LANCET,1998.837-853.
2Khandekar R,AILawatii J,Mohammed AJ. Diabetic retinopathy in Oman:a hospital based study[J].British Journal of Ophthalmology,2003.1061-1064.
3Knudsen LL,Lervang HH,Lundbye-Christensen S. The North Jutland Country Diabetic Retinopathy Study:population characteristics[J].British Journal of Ophthalmology,2006.1404-1409.doi:10.1136/bjo.2006.093393.
4Mitchell P,Moffitt P. Update and implications from the Newcastle diabetic retinopathy study[J].AustN Z J Ophthalmol,1990.13-17.
5Girach A,Vignati L. Diabetic microvascular complications-can the presence of one predict the development of another?[J].Journal of Diabetes and its Complications,2006.228-237.
7Adler AI,Stratton IM,Neil HA. Association of systolic blood pressure with macrovascular and microvascular complications of type 2 diabetes (UKPDS 36):prospective observational study[J].BMJ:British Medical Journal,2000.412-419.
9United Kingdom Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes:UKPDS 38[J].BMJ:British Medical Journal,1998.703-713.
10Kunt T,Schneider S,Pfuzner A. The effect of human proinsulin C-peptide on erythrocyte deformability in patients with type 1 diabetes mellitus[J].Diabetologia,1999.465-471.
9Van Leiden H A,Dekker J M,Moll A C,et al.Blood pressure,lipids,and obesity are associated with retinopathy.The Hoorn Study[J].Diabetes Care,2003,25:1320-1325.
10Aiello L P,Gardner T W,King G L,et al.Diabetic retinopathy[J].Diabetes Care,1998,21:143-156.
